Top Wall Street analysts initiated coverage on these top names. For a complete view of all analyst rating changes, including ...

Liquidia's collaboration with Sandoz and development of new products like L606 show promise. Learn why LQDA stock is a Hold.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

United Therapeutics (UTHR) announced that ten posters and presentations across its commercial and development portfolio will be presented at ...

A month has gone by since the last earnings report for United Therapeutics (UTHR). Shares have lost about 4.8% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...

United Therapeutics Co. has a fifty-two week low of $221.53 and a fifty-two week high of $417.82. The company has a market cap of $13.80 billion, a PE ratio of 13.49, a price-to-earnings-growth ...

We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against ...

Knight’s Latin American subsidiaries operate under United Medical, Biotoscana Farma and Laboratorio LKM. Knight Therapeutics Inc.’s shares trade on TSX under the symbol GUD. For more information about ...

Sun Pharmaceutical Industries Ltd and Nasdaq-listed Checkpoint Therapeutics ... and provide accelerated access to UNLOXCYT in the United States, Europe and other markets worldwide,” he said.

Three months after an FDA approval for cancer immunotherapy Unloxcyt, Checkpoint Therapeutics has found a buyer. Sun Pharma has agreed to purchase the Massachusetts biotech for an upfront value of ...